Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels
- 1 September 2017
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 27 (9) , 1109-1117
Abstract
Background Hyperthyroidism is associated with alterations in metabolism that currently are only partially understood. The objective of the study was to investigate changes in metabolism associated with reinstatement of euthyroidism in Swedish patients. Methods We profiled 80 metabolites in plasma from 10 subjects with Graves' disease at baseline and after 9 and 15 month of treatment to reinstate euthyroidism. Thyroid parameters, thyroid stimulating hormone (TSH), TSH receptor antibodies, free T3 and T4 were followed. Main findings were validated in plasma from 20 subjects with Graves' disease at baseline and at 3, 6, and 9 month. The study was conducted at the endocrinological clinic in Malmö, Sweden. Results Euthyriodism was reinstated at 3 month and thyroid status did not change further during the 15 month follow-up. This was paralleled by altered levels of 9 out of 19 detected acylcarnitines (p<0.05 after adjustment for multiple testing). Levels of short-chain acylcarnitines were decreased, levels of intermediate-chain acylcarnitines elevated and long-chain acylcarnitines unaltered. Conclusions Graves' disease and treatment of the disease is associated with pronounced acyl chain-length dependent alterations in acylcarnitine levels. These changes may be impacted by ethnicity and or dietary differences.Keywords
This publication has 43 references indexed in Scilit:
- Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' DiseaseThyroid®, 2016
- Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody ConcentrationsEuropean Thyroid Journal, 2016
- Long-Term Increased Carnitine Palmitoyltransferase 1A Expression in Ventromedial Hypotalamus Causes Hyperphagia and Alters the Hypothalamic Lipidomic ProfilePLOS ONE, 2014
- Thyroid Hormone as a Determinant of Energy Expenditure and the Basal Metabolic RateThyroid®, 2008
- In Vivo Regulation of Human Skeletal Muscle Gene Expression by Thyroid HormoneGenome Research, 2002
- Thyroid hormone excess and glucose intoleranceExperimental and Clinical Endocrinology & Diabetes, 2001
- Thyroid Hormone Regulates Carnitine Palmitoyltransferase Iα Gene Expression through Elements in the Promoter and First IntronJournal of Biological Chemistry, 2000
- Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid ratsFEBS Letters, 1996
- Changes in Carnitine Palmitoyltransferase-I mRNA Abundance Produced by Hyperthyroidism and Hypothyroidism Parallel Changes in ActivityBiochemical and Biophysical Research Communications, 1994
- Plasma Lipoproteins and Regulation of Hepatic Metabolism of Fatty Acids in Altered Thyroid States*Endocrine Reviews, 1985